Annual CFF:
$116.14M-$87.11M(-42.86%)Summary
- As of today, MLYS annual cash from financing is $116.14 million, with the most recent change of -$87.11 million (-42.86%) on December 31, 2024.
- During the last 3 years, MLYS annual cash from financing has risen by +$92.33 million (+387.75%).
- MLYS annual cash from financing is now -42.86% below its all-time high of $203.25 million, reached on December 31, 2023.
Performance
MLYS Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
$295.19M+$285.36M(+2902.62%)Summary
- As of today, MLYS quarterly cash from financing is $295.19 million, with the most recent change of +$285.36 million (+2902.62%) on September 30, 2025.
- Over the past year, MLYS quarterly cash from financing has increased by +$295.19 million (+29518900.00%).
- MLYS quarterly cash from financing is now at all-time high.
Performance
MLYS Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$494.39M+$295.19M(+148.19%)Summary
- As of today, MLYS TTM cash from financing is $494.39 million, with the most recent change of +$295.19 million (+148.19%) on September 30, 2025.
- Over the past year, MLYS TTM cash from financing has increased by +$378.26 million (+325.73%).
- MLYS TTM cash from financing is now at all-time high.
Performance
MLYS TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
MLYS Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -42.9% | +10000.0% | +325.7% |
| 3Y3 Years | +387.8% | +10000.0% | +322.2% |
| 5Y5 Years | +2932.4% | - | - |
MLYS Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -42.9% | +387.8% | at high | >+9999.0% | at high | +326.6% |
| 5Y | 5-Year | -42.9% | +2932.4% | at high | >+9999.0% | at high | +326.6% |
| All-Time | All-Time | -42.9% | +2932.4% | at high | >+9999.0% | at high | +326.6% |
MLYS Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $295.19M(+2902.6%) | $494.39M(+148.2%) |
| Jun 2025 | - | $9.83M(-94.8%) | $199.20M(+5.3%) |
| Mar 2025 | - | $189.28M(>+9900.0%) | $189.22M(+62.9%) |
| Dec 2024 | $116.14M(-42.9%) | $90.00K(+9100.0%) | $116.14M(+0.0%) |
| Sep 2024 | - | -$1000.00(+99.3%) | $116.13M(-0.2%) |
| Jun 2024 | - | -$152.00K(-100.1%) | $116.31M(+0.4%) |
| Mar 2024 | - | $116.20M(>+9900.0%) | $115.88M(-43.0%) |
| Dec 2023 | $203.25M | $74.00K(-59.8%) | $203.25M(+0.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | $184.00K(+131.7%) | $202.11M(+0.4%) |
| Jun 2023 | - | -$581.00K(-100.3%) | $201.36M(-37.0%) |
| Mar 2023 | - | $203.57M(>+9900.0%) | $319.59M(+175.5%) |
| Dec 2022 | $128.02M(+437.6%) | -$1.07M(-90.4%) | $116.02M(-0.9%) |
| Sep 2022 | - | -$561.00K(-100.5%) | $117.09M(-0.5%) |
| Jun 2022 | - | $117.65M | $117.65M |
| Dec 2021 | $23.81M(+521.7%) | - | - |
| Dec 2020 | $3.83M | - | - |
FAQ
- What is Mineralys Therapeutics, Inc. annual cash from financing?
- What is the all-time high annual cash from financing for Mineralys Therapeutics, Inc.?
- What is Mineralys Therapeutics, Inc. annual cash from financing year-on-year change?
- What is Mineralys Therapeutics, Inc. quarterly cash from financing?
- What is the all-time high quarterly cash from financing for Mineralys Therapeutics, Inc.?
- What is Mineralys Therapeutics, Inc. quarterly cash from financing year-on-year change?
- What is Mineralys Therapeutics, Inc. TTM cash from financing?
- What is the all-time high TTM cash from financing for Mineralys Therapeutics, Inc.?
- What is Mineralys Therapeutics, Inc. TTM cash from financing year-on-year change?
What is Mineralys Therapeutics, Inc. annual cash from financing?
The current annual cash from financing of MLYS is $116.14M
What is the all-time high annual cash from financing for Mineralys Therapeutics, Inc.?
Mineralys Therapeutics, Inc. all-time high annual cash from financing is $203.25M
What is Mineralys Therapeutics, Inc. annual cash from financing year-on-year change?
Over the past year, MLYS annual cash from financing has changed by -$87.11M (-42.86%)
What is Mineralys Therapeutics, Inc. quarterly cash from financing?
The current quarterly cash from financing of MLYS is $295.19M
What is the all-time high quarterly cash from financing for Mineralys Therapeutics, Inc.?
Mineralys Therapeutics, Inc. all-time high quarterly cash from financing is $295.19M
What is Mineralys Therapeutics, Inc. quarterly cash from financing year-on-year change?
Over the past year, MLYS quarterly cash from financing has changed by +$295.19M (+29518900.00%)
What is Mineralys Therapeutics, Inc. TTM cash from financing?
The current TTM cash from financing of MLYS is $494.39M
What is the all-time high TTM cash from financing for Mineralys Therapeutics, Inc.?
Mineralys Therapeutics, Inc. all-time high TTM cash from financing is $494.39M
What is Mineralys Therapeutics, Inc. TTM cash from financing year-on-year change?
Over the past year, MLYS TTM cash from financing has changed by +$378.26M (+325.73%)